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Abstract.  The properties of keratin-containing  inter- 
mediate filament (IF) networks in vivo were studied 
following the microinjection of biotinylated keratin. 
Keratin-IFs were biotinylated, disassembled, and sep- 
arated into type I and type II proteins by ion exchange 
chromatography.  Recombination of these derivatized 
type I and type II keratins  resulted in the formation 
of 10-nm diameter IF.  The type I keratins  were mi- 
croinjected into epithelial cells and observed by im- 
munofluorescence microscopy. Biotin-rich spots were 
found throughout the cytoplasm at  15-20 min after 
injection.  Short biotinylated fibrous structures were 
seen at 30--45 min after injection,  most of which 
colocalized with the endogenous bundles of IF (tono- 
filaments).  By 1  1/2 to 2  h  after microinjection,  ex- 
tensive biotinylated keratin IF-like networks were 
evident.  These were highly coincident with the en- 
dogenous tonofilaments throughout the cell, includ- 
ing those at desmosomal junctions.  These results 
suggest the existence of a  relatively rapid subunit in- 
corporation mechanism using numerous sites along 
the length of the endogenous tonofilament bundles. 
These observations support the idea that keratin-IFs 
are dynamic cytoskeletal elements. 
ERATIN is the major component of epithelial  cell in- 
termediate  filaments  (IFs) t.  Keratin-IFs  typically 
are found in tightly packed bundles known as tono- 
filaments  which are distributed throughout the cytoplasm 
(19, 32, 34). At the cell center they form an elaborate cage 
around the nucleus (34) and appear to be attached to the nu- 
clear surface (28, 33). Tonofilaments extend from the nuclear 
region to the cell periphery where they associate with des- 
mosomal plaques in regions of  cell-cell contact (5, 32). Kera- 
tin IFs contain types I (acidic) and II (neutral-basic)  IF pro- 
teins  (23, 65). These two types have been characterized  by 
their isoelectric points  (17, 45), sequence homologies (22, 
45, 50, 60, 63, 64, 66), and immunoreactivity (17). In vitro 
polymerization studies  have demonstrated that both type I 
and type II keratins  are required for 10-nm filament forma- 
tion at the heterodimer level (7, 14, 48, 58) and for this rea- 
son they are termed obligate copolymers (29, 61). 
In contrast to the dynamic properties of other cytoskeletal 
systems,  (24,  27,  54,  73),  IFs,  including  keratin  IF,  are 
thought to be relatively stable components of the cytoskele- 
ton of interphase  cells (8).  This latter notion can be attrib- 
uted to the finding that IFs are insoluble in vitro under physi- 
ological conditions and that in general there is little evidence 
for the existence of pools of "soluble" subunit proteins in 
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1. Abbreviations  used in this paper: IF, intermediate filament; PME, pri- 
mary mouse epidermal. 
the cytosolic compartments of interphase  cells. In contrast, 
there is evidence that IFs, including keratin-IF,  are dynamic 
with respect to their disassembly and subsequent reassembly 
during mitosis in some cell types (6, 20, 31, 34, 40, 51). In 
support of these morphological findings, it has been shown 
that the cell cycle regulator,  p34  ~dc-2, phosphorylates and in- 
duces the disassembly of the type HI vimentin-IF system in 
fibroblasts (13), and the type V IF system comprising the nu- 
clear lamina (49) before cell division.  Furthermore, fluores- 
cence energy transfer techniques have revealed that there is 
an exchange of subunit  proteins in neuronal  IF (neurofila- 
ments)  in vitro (4). 
Recently,  cDNA  transfection  experiments  have  shed  a 
great deal of light on the mechanisms  of keratin IF assembly 
in vivo and have also provided useful clues regarding the dy- 
namic properties of interphase  keratin  IF networks.  It has 
been found that newly s~thesized wild-type keratin is incor- 
porated into the endogenous keratin IF network by 65 h after 
transfection (1, 2, 26). The results also have shown which do- 
mains of the keratin molecule are essential for the assembly 
of newly synthesized  keratin into tonofilaments  (1, 2, 42). 
Deletion constructs producing proteins that  lack both the 
amino-terminal  domain and the amino-terminal  end of the 
central  rod domain induce the disruption of the endogenous 
tonofilaments  into  perinuclear  aggregates  of keratin  (2). 
Similar  mutants  lacking  both the carboxy-terminal  domain 
and the carboxy end of the central  rod domain result in the 
formation  of large  cytoplasmic keratin-rich  aggregates  as 
well as a disrupted endogenous network (1). This effect is 
most likely due to an abortive incorporation of defective ker- 
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siently transfected cells begin to recover and reform an en- 
dogenous tonofilament system beginning in the juxtanuclear 
region,  suggesting the presence of a keratin IF organizing 
center at or near the nuclear surface (2,  14,  16, 25). Other 
in vivo studies have employed the microinjection of keratin 
mRNA to induce the synthesis of keratin IF in living epithe- 
lial (21) and nonepithelial (37) cells. In contrast, the results 
of these experiments indicate that assembly of newly synthe- 
sized IF protein occurs at discrete locations throughout the 
cytoplasm  of cells  devoid of endogenous  keratin  IF  net- 
works. 
Transfection experiments using other types of IF systems 
have been carried out. For example, a similar juxtanuclear 
accumulation is found 18-24 h after transfection with type 
IV IF cDNA constructs (neurofilamen0 in fibroblasts (11). 
The  initial  sites  of  incorporation  of  newly  synthesized 
vimentin in 3T3 fibroblasts appear to occur throughout the 
endogenous vimentin IF network after induction of a trans- 
fected chicken vimentin gene (46). On the other hand, trans- 
fected mouse vimentin is first observed in a perinuclear re- 
gion after its induction in human cells and is last observed 
in the juxtanuclear region after the cessation of the induction 
(53). In studies in which the vimentin network appears to be 
absent in cells, the assembly of newly synthesized vimentin 
appears to occur throughout the cytoplasm (53). 
The  dynamic  properties  of microtubules  and  microfila- 
ments in situ and in vivo have been elucidated by following 
the distribution of microinjected tubulin or actin labeled with 
various  "reporter"  molecules  such  as  fluorescein,  rhoda- 
mine, and biotin (36, 41, 43, 44, 47, 52, 72). In general, ex- 
periments employing such methods have demonstrated that 
microinjected subunits exchange very rapidly with the appro- 
priate endogenous polymer systems. Actin is associated with 
the microfilaments comprising stress fibers within 5-20 min 
(3); tubulin is incorporated into microtubules in 7 min (56); 
and the type III IF protein, vimentin, is incorporated into IF 
within 60 rain (70). 
To date, the direct injection of biotinylated keratin has not 
been used to study the properties of the keratin-rich tonofila- 
ment system in epithelial cells. This is due to the inherent 
difficulties in obtaining purified type I or type II keratins in 
an injectable form (21). We have been able to overcome this 
problem and have carried out studies aimed at determining 
the fate of microinjected biotinylated type I keratin into pri- 
mary mouse epidermal (PME) and into kangaroo rat kidney 
epithelial (PtK2) cells. Our results demonstrate that the mi- 
croinjected keratin  is incorporated  into tonofibrils in vivo 
over relatively short time periods, indicating that the keratin- 
IF system is more dynamic than previously indicated. 
Materials and Methods 
Cell Culture 
PME ceils were isolated by the trypsin flotation procedure of Yuspa and 
Harris (75) as described by Jones and Goldman (32). Cells were plated onto 
locator coverslips 0kllco Glass Inc., Vineland, N J) and observed in normal 
Ca2+-containing MEM  (Gibco Laboratories,  Grand Island,  NY).  Under 
these conditions, keratin IF networks extend to the cell surface and normal 
desmosome formation takes place in areas of cell-cell contact (32). PtK2 
cells were grown in MEM  (Gibco Laboratories,  Grand Island, NY) and 
plated onto loeator coverslips 24--48 h before microinjection. BHK-21 cells 
were cultured as described elsewhere (70). 
Preparation of Biotinylated 1)pe I Keratin 
Fresh bovine tongues were obtained from the slaughterhouse and immedi- 
ately immersed  in crushed ice.  Within 1-2 h  the mucosa was removed; 
soaked in 20 mM EDTA/I mM PMSF/PBSa, pH 7.4, at 4°C for 12 h; pulled 
away from the underlying dermis with forceps; and minced with scissors 
(35). Keratin ITs were prepared by extraction with urea buffer A (8 M urea, 
50 mM Tris-HCl, pH 9.0,  20 mM/~-mercaptoethanol, and 1 mM PMSF) 
for 45-60 rain at 4°C with vigorous stirring (35, 57). Urea-insoluble mate- 
riai was removed by centrifugation at 200,000 g  for 30 rain. The protein 
concentration in the supernatant was determined by the Bradford method 
(10) and adjusted to 1.4 mg/ml with urea buffer A. This latter solution was 
dialyzed against 50 vol (2 ×) of assembly buffer (10 mM Tris-HC1, pH 7.4, 
0.1 mM PMSF) overnight at room temperature to polymerize keratin IE Po- 
lymerization was assayed by negative staining with 1% uranyl acetate on 
parlodion/carbon-coated copper grids, using a JEOL 1200EX electron mi- 
croscope. 
Polymerized IFs were biotinylated as follows: 200 mg of the labeling re- 
agent, Succinimidyl-D-biotin (Molecular Probes, Eugene, OR), was dis- 
solved in 55 ml of dimethylformamide (Fisher Scientific, Fair Lawn, NJ) 
immediately before use and was pipetted slowly into 500 ml of keratin IF 
in 10 mM Tris, pH 7.4, kept in suspension with continual stirring. This reac- 
tion mixture was incubated at room temperature for 30 rain with occasional 
stirring. IFs were removed from the labeling reaction by centrifugation at 
200,000 g for 30 min at 10°C. The resulting pellet was resuspended immedi- 
ately in urea buffer B (8 M urea, 5 mM NaPO4, pH 7.4, 0.2% #-mereapto- 
ethanol,  1 mM PMSF) in order to depolymerize IFs, which were subse- 
quently repolymerized by dialysis against assembly buffer. This procedure 
was repeated once. To insure that IFs were forming, twice-cycled prepara- 
tions were assayed by negative staining. 
The 48/54-kD type I (acidic) and the 62/67-kD type II (neutral-basic) bi- 
otinylated bovine tongue keratins were separated by ion exchange chroma- 
tography (model DE-52; Whatman Chemical Separation, Inc., Clifton, N J) 
(1.0  x  32 cm column), using a modification of the procedure of Steinert 
and Idler (59). Specifically, twice-cycled biotinylated IFs were collected by 
centrifugation at 200,000 g  for 30 min and disassembled in column buffer 
(9.5 M urea, 20 mM Tris-HC1, pH 8.6,  1 mM EDTA,  1 mM DTT).  The 
solubilized biotinylated keratins were applied to the column, washed, and 
eluted at 30 ml/h. Type II keratins were found in the flow through fraction. 
Type I keratins were eluted with a 200-ml linear salt gradient (0-100 mM 
NaC1) in column buffer. 1-ml fractions were collected and every third frac- 
tion was assayed by SDS-PAGE (39). Fractions containing the type I kern- 
tins were pooled and exhaustively dialyzed against 10 mM Tris, pH 7.4. 
These preparations were found to be suitable for microinjection and type 
I keratins remained in solution after centrifugation at 100,000 g for 30 min. 
No IFs were seen in this preparation by negative stain EM. Aliquots (200 
#1) were  frozen in liquid nitrogen and stored for microinjection experi- 
ments. In contrast, the type II proteins found in the flow through fraction 
were much more difficult to keep in solution. To date, despite numerous at- 
tempts using  a  variety  of physiologically  acceptable buffers,  conditions 
compatible with microinjection into live cells have not been found for the 
62/67 kD type II keratins. 
Preparation of Biotinylated Vimentin 
Biotinylated vimentin was prepared as described elsewhere (70, 71). 
Western Blotting 
Immunoblotting was carried out by the method of Towbin et al. (69). AE1 
and AE3 keratin antibodies were provided by Dr. T. T. Sun (New York Uni- 
versity College of Medicine) and were used at a dilution of 1:50. A previ- 
ously characterized rat monoclonai antikeratin (mAb anti-K) (30) was used 
undiluted. In order to detect biotinylated keratin, goat antibiotin antibody 
(Sigma Chemical Co.,  St.  Louis,  MO)  was used at  1:1,000.  Peroxidase- 
conjugated secondary antibodies included rabbit antigoat (Amersham, Ar- 
lington Heights, IL), goat antirat (Jackson Immunoreseareh Laboratories, 
Inc., West Grove, PA), and goat antimouse (Southern Biotechnologies As- 
sociates, Inc., Birmingham, AL), all used at a dilution of 1:1,000.  Antivi- 
mentin antibody was previously characterized (70). 
Keratin IF Isolation 
IFs from cultured PME cells were isolated using the method of Zackroff and 
Goldman (76). The final pellet was washed three times in PBSa and frozen 
at  -80°C  for use in immunoblotting assays. 
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Microinjections were carried out as described in Vikstrom et al. (70, 71). 
Micropipettes were made with a vertical pipette puller (David Kopf Instru- 
ments, Tujunga, CA). Frozen aliquots of biotinylated keratin were thawed 
and the protein concentration in the sample to be injected was adjusted to 
0.75-1 mg/ml (10). The samples were clarified in an Eppendorf microfuge 
for 2 min  before microinjection. After microinjection, the dishes containing 
the cells on locator coverslips (see above) were returned to the incubator. 
At  appropriate  time  intervals,  cells  were  fixed and  processed  for  im- 
munofluorescence. Other researchers (3, 56) have estimated that 10% or 
less of the cell volume can be microinjected successfully into the ceil. 
Indirect Immunofluorescence 
PME and PtK2  cells were processed for double-label indirect immunofluo- 
rescence as previously described (74). BHK-21  cells were fixed in 0.1% glu- 
taraldehyde/0.15% Triton X-100/PBSa for 8 rain and the  free aldehyde 
groups reduced through three washes of 5 rain each in a solution of 1 rng/ml 
sodium borohydride (55). Goat antibiotin (Sigma Chemical Co.) was used 
to detect biotinylated bovine keratin. In uninjected cells, a very low level 
of  background mitochondrial staining (38) was detected using this antibody. 
However, in  microinjected ceils the biotin-keratin signal was so much greater 
than the mitochundrial staining that it was not obvious, mAb anti-K was 
used to detect the endogenous PME keratin IF network (34). mAb anti-K 
did not recognize the bovine tongue type I keratins by Western blotting (see 
Fig. 3). A rabbit polyclonal directed against the mouse keratin K2 was used 
to detect the endogenous keratin IF networks of PtK2 cells (33). This anti- 
body also reacted with the bovine type I keratin by Western blotting, but 
the two distinct patterns obtained from indirect immunofluorescence stain- 
ing at early times afer microinjection (see Fig. 7, A and B) demonstrated 
that the antibiotin antibody clearly distinguished the microinjected keratin 
from the endogenous PtK2 keratin. 
Rhodamine-conjugated donkey antirat (Jackson Immunoresearch), fluo- 
rescein-cenjugated donkey antigoat, and rhodamine-conjugated donkey  anti- 
rabbit (Jackson Immunoreseareh) were used as secondary antibodies. A 
Zeiss Axiophot microscope was used to observe and photograph the cells. 
Cycloheximide Treatment 
In some experiments, PtK2 cells were treated with 10/~g/ml cycloheximide 
(Sigma Chemical Co.) for I h or more before microinjection and maintained 
in the same culture medium during microinjection and subsequent incuba- 
tions. This treatment inhibited 90-95 % of protein synthesis as measured by 
35-S methionine CICN Biomedieals, Inc., Irvine,  CA) incorporation into 
PtK2 cells.  Specifically, 60-ram dishes  of subconfluent PtK2 cells were 
washed 3× in 1 mM MgC12/PBS and treated with either 0 or 10/~g/ml ey- 
cloheximide in methionine-free MEM (lqorthwestern University Cancer 
Center, Chicago, IL) containing 5 t~Ci/ml 35-S methionine. After incuba- 
tion at 37°C for 15, 30, 60, 120, and 240 rain, cells were lysed in a solution 
of  0.5 % SDS, 0.5 M NaCI, 5 mM EDTA  and removed using a rubber  police- 
man. Protein was then precipitated with TCA using BSA as a carrier and 
stored on ice for the duration of  the experiment. Suspensions of  precipitated 
protein were filtered through glass mierofiber filters (model GF/G; What- 
man Inc., Clifton, NJ), extensively washed with cold TCA, and counted in 
a liquid scintillation counter (model LS 6800; Beckman Instruments Inc., 
Palo Alto, CA). 
Results 
Characterization of  Biotinylated Keratin 
Keratin IFs prepared from bovine tongue epithelium, consist 
primarily of two major and two minor keratin bands of 67, 
62,  54 and 48 kD (Fig.  1 A).  This mixture of proteins has 
been biotinylated in their polymerized form so as to protect 
the molecular domains important for assembly (see Materi- 
als and Methods). After two cycles of assembly-disassembly, 
biotinylated keratin IFs appear normal as assayed by negative 
staining  (Fig.  1  C).  This  demonstrates  that  biotinylation 
does not affect the overall polymerization of keratin. SDS- 
PAGE analyses of these  twice-cycled biotinylated IF show 
that the overall profile of keratins is  very  similar to unbi- 
otinylated preparations,  showing only a  slight upward shift 
in relative mobility (Fig.  1 B). 
After the second cycle of in vitro polymerization, biotinyl- 
ated keratin IFs were collected by centrifugation, disassem- 
bled in column buffer, applied to a DE-52 cellulose column, 
and the resulting fractions assayed by SDS-PAGE (Fig. 1 D; 
see Materials and Methods).  The 67/62-kD higher molecu- 
lar mass keratins are collected in the flow through fraction 
(Fig.  1 E), and the 54/48-kD lower molecular mass keratins 
Figure 1. (A) Bovine tongue epi- 
thelium was extracted with urea 
buffer  and  dialyzed  against  as- 
sembly buffer to form IFs. These 
were  characterized  by  SDS- 
PAGE and stained with Coomas- 
sie blue (the same is true for lanes 
B, D, E, and F). Two major and 
two minor bands of 67,  62,  54, 
and 48  kD  are evident.  Arrows 
denote type I keratins, and open 
circles denote type II keratins (see 
Fig.  2).  (B) Biotinylated bovine 
tongue keratin IFs after  cycling 
through two rounds of disassem- 
bly/assembly. (C) Negative stain 
electron micrograph of the twice- 
cycled  biotinylated  keratin  IE 
(D-F) Biotinylated  bovine  tongue 
type  I  keratins  separated  from 
type II keratins by DE-52 column 
chromatography.  (D)  Column 
load of twice-cycled biotinylated 
keratin IE (E) The type II kera- 
tins found in the flow through. (F) 
Eluted  type I keratins. Bar, 0.1/~M. 
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bovine  tongue  keratin  IF  with 
AEI  and  AE3  mAbs. AE3  has 
been  shown to  react  primarily 
with  type II  keratins,  and  AEI 
with type I keratins (14). Nonbi- 
otinylated bovine tongue keratins 
(lane 1,  SDS-PAGE, Coomassie 
blue) were transferred to nitrocel- 
lulose and probed with AE3 (lane 
2) and AE1 (lane 3).  (open cir- 
cles) 67 and 62 kD;  (asterisks) 
54 and 48 kD. 
begin to elute at ,~45 mM NaC1 using a 0-100-mM linear 
NaCI  gradient  (Fig.  1 F).  Neither the  higher  molecular 
weight  fraction  nor the  lower molecular  weight  fraction 
alone can be induced to polymerize into IF when dialyzed 
against assembly buffer. However, when the 62/67-kD frac- 
tion is recombined with the 54/48-kD fraction at approxi- 
mately equal concentrations (0.33 mg/ml) in column buffer, 
large numbers of 10-nm diameter IFs form rapidly upon dial- 
ysis against assembly buffer. These appear identical to those 
seen in Fig. 1 C. This demonstrates that the column purifica- 
tion procedure does not inhibit keratin polymerization. 
Immunoblotting analyses with the AE1 and AE3 antibod- 
ies have been used to distinguish acidic and basic keratins 
(see Materials and Methods; 14). AE1 reacts mainly with the 
48- and 54-kD keratins, indicating their acidic type I charac- 
ter (Fig.  2,  lane 3),  while AE3 reacts primarily with the 
62-  and  67-kD  species,  demonstrating their basic  type II 
character (Fig. 2, lane 2). The type I fraction used for micro- 
injection has been further analyzed by 2-D gel electrophore- 
sis. The 48-kD protein focuses at pH 5.0-5.5 as a single spot, 
while the 54-kD keratin is only slightly more basic, further 
confirming their type I acidic nature (data not shown). The 
48- and 54-kD species are present in an approximate ratio of 
95 to 5 %, respectively, as shown by densitometric scanning 
of Coomassie blue-stained SDS-PAGE gels of the type I-en- 
riched column fractions. 
The antibodies to be used for immunofluorescence obser- 
vations of microinjected mouse epidermal cells have been 
analyzed  by  immunoblotting.  Antibiotin  antibody  reacts 
specifically with both biotinylated type I  keratins  (Fig.  3, 
lane 2). mAb anti-K is specific for the 48-kD keratin of PME 
IF (Fig. 3, lane 5), and does not react with the bovine tongue 
keratins (Fig. 3, lanes 3 and 8). These results demonstrate 
that we can clearly distinguish the biotinylated protein from 
the endogenous mouse keratin in PME cells. 
Microinjection Experiments 
On average, 45 cells on locator coverslips can be injected in 
20 rain. Each injected cell is observed by phase contrast and 
its position on the locator grid is noted along with the exact 
time of injection. The coverslips are then returned to the in- 
cubator. At time points after injection, cells on coverslips are 
fixed and double-label indirect immunofluorescence is car- 
ried out using goat antibiotin and mAb anti-K. At 20 min, 
antibiotin  staining  reveals  a  pattern  of bright  spots  dis- 
tributed in all areas of the cytoplasm (Fig. 4 A), while the 
endogenous keratin network retains its normal appearance 
(Fig. 4 B). By 30-45 min after injection, few spots remain 
obvious  and  short  biotin-positive  filamentous  structures 
which tend to form a fine reticular pattern are seen through- 
out the cytoplasm (Fig. 4,  C and/9).  Some of,the obvious 
linear elements of this pattern appear to colocalize with the 
endogenous keratin IF tonofilaments (arrowheads),  although 
the closely spaced tonofilaments and diffuse fluorescence 
seen in the thicker regions of the cytoplasm limit resolution 
at this stage. In a few peripheral regions of the cell, no obvi- 
ous colocalization is seen (Fig. 4,  C and D, arrows).  From 
40-90 min after microinjection an increase is  seen in the 
Figure 3.  Immunoblot analyses of antibiotin 
and mAb anti-K. Preparations of biotinylated 
type I keratins, PME cell IF, and unlabeled bo- 
vine tongue  keratin  IF  (lanes  1,  4,  and  7, 
respectively;  SDS-PAGE,  Coomassie  blue) 
were transferred to nitrocellulose and probed 
with goat antibiotin antibody (lanes 2, 6, and 
9).  The 48-  and  54-kD  keratins  of the  bi- 
otinylated type I  keratin preparation  reacted 
(lane 2). The antibiotin antibody did not react 
with PME IF or unlabeled bovine tongue kera- 
tin (lanes 6and 9). mAb anti-K was specific for 
the 48-kD keratin of the PME IF preparation 
(lane 5) and it did  not react  with either  bi- 
otinylated or unlabeled bovine keratin (lanes 3 
and 8). 
The Journal of Cell Biology,  Volume 113, 1991  846 clarity of the antibiotin pattern,  as the fine reticular and 
diffuse fluorescence patterns  disappear  and tonofilament- 
like structures are readily distinguished (Fig. 4, E and F). 
By 90-120 min, most of the biotinylated type I keratin is 
found to be highly coincident with endogenous tonofilaments 
throughout the cell (Fig. 4, G and H). At the cell surface the 
biotin pattern appears to be superimposed on tonofilaments 
aligned at desmosomal junctions (Fig. 5, A and B). 
Due to the overall thickness of cultured keratinocytes, it 
has been difficult to observe the morphological details of the 
transition from the biotinylated keratin spots (seen at short 
time intervals after microinjection) to the tonofilaments seen 
at later times. To gain additional insights into this process 
we have used PtK2 cells. These simple epithelial cells are 
larger,  flatter, and possess  fewer tonofilaments which are 
also well separated. These are all properties that facilitate 
detailed studies of individual tonofilaments by fluorescence 
microscopy.  Using  single-label  immunofluorescence with 
antibiotin, spots are seen throughout the cell at 15-20 min 
after injection (data not shown). After 45-60 min, most of 
the biotin-containing spots are no longer visible and short 
wavy filamentous structures are seen throughout the cyto- 
plasm from the nuclear region to the cell periphery (Fig. 6). 
Double-label  immunofluorescence has  been  employed to 
determine whether or not the spots and short filaments of bi- 
otinylated keratin seen at early time points are associated 
with endogenous tonofilaments. At 15-20 min after injec- 
tion, spots of biotinylated keratin appear to be distributed 
throughout the cell (Fig. 7, A and B). However, double label- 
ing at this time period to reveal the endogenous network of 
tonofilaments shows an apparent absence of spots as seen in 
Fig. 7 B. This is somewhat surprising as the antikeratin poly- 
clonal recognizes the injected bovine tongue type I keratin 
by immunoblotting (see Materials and Methods). One possi- 
ble explanation for this observation is that the majority of 
spots are closely associated with the endogenous tonofila- 
ments at this time interval after injection. In support of this 
possibility,  preliminary  morphometric  analyses  have  in- 
volved the superimposition of double-label immunoffuores- 
cence micrographs (such as Fig. 7, A and B) taken at ~15-20 
min after injection. In all cases,  the vast majority of bi- 
otinylated keratin spots overlie endogenous tonofilaments 
(data not shown; similar results were also obtained in PME 
cells). By 60 min after injection most spots are no longer ob- 
vious in PtK2 cells and discontinuous fibrils containing bi- 
otinylated keratin appear coaligned with endogenous tono- 
filaments (Fig. 7,  C and D, arrows).  Between 2--4 h after 
injection extensive overlap  is  seen  between the  biotinyl- 
ated keratin pattern and endogenous tonofilaments (Fig. 7, 
E and F). 
Moreover, PtK2 cells also possess a type [] IF network, 
containing vimentin. We have used this latter property to de- 
termine whether or not keratin IF and vimentin IF exhibit 
different incorporation patterns within the same cell type as 
suspected from our previous studies employing biotinylated 
vimentin microinjected into fibroblasts (70).  Indeed, when 
biotinylated vimentin is microinjected into PtK2 cells, a pat- 
tern distinct from that of biotinylated keratin is observed. 
Immediately after injection, spots of  biotin-vimentin are dis- 
tributed throughout the cytoplasm. At 60 min, the majority 
of spots are found in a large juxtanuclear region (Fig. 8, A 
and B). Within 2--4 h biotinylated vimentin-containing fi- 
bers are seen at the edge of the juxtanuclear region, and at 
later time intervals most of  the biotinylated vimentin is found 
to be coincident with the endogenous vimentin network (Fig. 
8, C and D). The endogenous vimentin network appears nor- 
mal at all time points. Therefore, the overall pattern of incor- 
poration of vimentin into the endogenous type 111 IF network 
appears to be different from the pattern seen for keratin in 
the same cell type. 
Several additional controls have been carried out for these 
microinjection experiments. To determine whether any fluo- 
rescence in the cell could be due to background caused by 
unconjugated biotin, we have microinjected succinimidyl bi- 
otin alone which has been treated in a fashion identical to 
that used in the keratin labeling reaction. No detectable sig- 
nal is found after the ceils are processed for indirect immuno- 
fluorescence. In addition, after microinjection ofbiotinylated 
keratin, the overall pattern of other cytoskeletal elements 
such as microtubules appears normal for periods up to 2 1/2 h 
after injection (data not shown). 
To demonstrate the importance of a type 1I keratin partner 
in the assembly process, the biotinylated type I keratin has 
been injected into BHK-21  cells which contain the type [] 
IF proteins, vimentin and desmin, (76) without any obvious 
keratin. 4 h after microinjection, the biotinylated keratin is 
seen as nonfilamentous aggregates near the nucleus (Fig. 9, 
A and B). 
We have also determined the fate of microinjected type I 
biotinylated keratin in PtK2 cells treated with cycloheximide. 
These experiments have allowed us to distinguish whether or 
not the type II partner proteins presumably needed for as- 
sembly into tonofilaments are derived from newly synthe- 
sized proteins or from existing endogenous proteins. Under 
these conditions 90-95 % of protein synthesis is inhibited as 
assayed by the incorporation of 35S-methionine  into total 
cell protein (see Materials and Methods). After injection, bi- 
otinylated keratin incorporates into extensive arrays of tono- 
filaments within 4 h (data not shown). No disruption of the 
endogenous keratin IF networks is observed in either injected 
or noninjected cells treated with cycloheximide  for this same 
time period. Therefore, newly synthesized type II protein is 
not necessary for the incorporation of the injected keratin 
into tonofilaments. 
Discussion 
In this study, we have determined the fate of microinjected 
biotinylated keratin. To initiate these studies, we have devel- 
oped a procedure for separating biotinylated keratin IF into 
type I and type II proteins. As a result we have been able to 
inject single cells with type I keratin alone. Our findings in- 
dicate that these keratins are rapidly incorporated into the 
endogenous tonofilament network by immunofluorescenee 
criteria. This provides us with a simple approach for study- 
ing various aspects of the posttranslational assembly and dy- 
namics of keratin-containing tonofilaments under different 
physiological conditions. It also provides the foundation for 
further investigations of the function and dynamic nature of 
keratin-IF in vivo using methods such as fluorescence recov- 
ery after photobleaching (68). 
Miller et al. Incorporation of Biotinylated Keratin  847 Figure  4.  Time course of biotinylated type I  keratin incorporation. Biotinylated type I keratin was microinjected into PME cells and 
processed for double-label indirect immunofluorescence using goat antibiotin (A, C, E, and G) and mAb anti-K (B, D, F, and H) at 20 
min (A and B); 40 min (C and D); 60 min (E and F); and 90 min (G and H) after microinjection. Some linear arrays of biotinylated 
spots can be seen in areas of cell-cell contact in Fig. 4 A. A, E, and G, additional injected cells are denoted with i. Bar,  10 tzM. 
The Journal of Cell Biology,  Volume 113, 1991  848 Miller ¢t al. Incorporation of Biotinylated Keratin  849 Figure 5. Incorporation of microinjected biotinylated type I keratin into tonofilaments in areas of cell-cell contact in PME ceils. Cells 
were fixed  at 90 min postinjection and stained with goat antibiotin (A) and mAb anti-K (B). In A only the top cell was injected. Bar, 5 #M. 
After microinjection, the biotinylated type I keratin prepa- 
ration assembles through a series of discrete, reproducible 
steps into a tonofilament-like network. Biotinylated keratin 
is seen first as bright spots dispersed throughout the cyto- 
plasm. These spots disappear, as short and then longer tono- 
filaments appear. These observations suggest that the keratin 
aggregates give rise to the short tonofilaments that subse- 
quently elongate to form a complete network by 1 1/2-2 h 
using light microscopic criteria in PME cells. Furthermore, 
Figure  6.  PtK2 cells were micminjected with biotinylated type I 
keratin. 40 min after microinjection the cells were processed for 
single-label immunofluorescence with  antibiotin antibody. Bar, 
10 #m. 
the biotinylated keratin-tonofilament  network is very similar 
to the endogenous network. These results suggest that biot- 
inylated type I keratin is incorporated into the endogenous 
network at numerous sites.  These observations add to the 
growing body of literature indicating that IFs are dynamic 
cytoskeletal  elements with regard to protein subunit exchange 
(2,  12,  33, 51, 70). 
There are numerous possible mechanisms by which the in- 
corporation of microinjected subunits could take place. For 
example, if tonofilaments contain short IF with free ends at 
different points along their length, then individual IF could 
be lengthened by the addition of keratin subunits onto one 
or both ends. Alternatively, if individual IFs are continuous 
along the entire length of the tonofilament, then exchange of 
subunits could take place at certain locations along the length 
oflE This latter possibility assumes that there are "hot spots" 
at which incorporation of subunits occurs at higher rates. 
Both of these possibilities could explain the formation of bi- 
otinylated spots, as well as the short discontinuous filaments 
seen in close association with tonofilaments at early time 
points after injection. Both of these mechanisms are consis- 
tent with the overall general model recently proposed by 
Coulombe and Fuchs (14). It should be emphasized that these 
alternatives cannot be distinguished at the light microscopic 
level of resolution. We may be able to gain more insight into 
these  mechanisms  in experiments  now in progress  using 
higher resolution avidin-gold labeling (7). 
Microinjection of keratin mRNA also has been used to 
suggest a  "multiple-site" mechanism for  the  assembly of 
newly synthesized keratin into tonofilament-like structures 
in nonepithelial cells. These structures are evident at 12-24 h 
after injection. In these studies the microinjection samples 
contain both types I and II keratin mRNA (36).  When simi- 
lar samples are injected into epithelial cells, the newly syn- 
thesized keratin is found  assembled into the endogenous  tono- 
filament network 6 h after microinjection (21). However, the 
number and distribution of assembly sites have not been de- 
termined in these cells (21), but the results do suggest that 
newly synthesized keratin can be incorporated into an estab- 
lished keratin IF network. 
Therefore, all available information suggests that there are 
multiple mechanisms which exert their control at the tran- 
scriptional,  cotranslational, and posttranslational levels to 
regulate keratin IF polymerization within epithelial ceils. In 
addition, transient transfection studies have suggested that 
The Journal of Cell Biology, Volume  113, 1991  850 Figure 7.  PtK2 cells were microinjected with biotinylated  type I keratin. At 20 min (A and B),  1 h (C and D), and 4 h (E and F) after 
injection the cells were processed for double-label  indirect immunofluorescence using goat antibiotin  (A, C, and E) and a rabbit polyclonal 
against  keratin (B, D, and F).  Bar,  5/~m. 
Miller et aL Incorporation of Biatinylated Keratin  851 Figure 8. PtK2 were microinjected with biotinylated vimentin. At 60 rain (A and B), and 16 h (C and D) after injection the cells were 
processed for double-label indirect immunofluorescence  using goat antibiotin (A and C) and a polyclonal  against vimentin (B and D). Bar, 
10 ,am. 
there is a nuclear-associated assembly mechanism involved 
in the incorporation of newly synthesized keratin into tono- 
filaments (1, 2). Our data suggest that there is a posttrans- 
lational  exchange  of keratin  subunits  into  tonofilaments 
which permits incorporation throughout the keratin IF net- 
work;  including the nuclear region, elsewhere throughout 
the cytoplasm, and at the cell surface in regions containing 
desmosomes. 
In contrast to the results with biotinylated keratin, micro- 
injected biotinylated  vimentin shows a rapid accumulation in 
a large juxtanuclear region in cultured BHK-21 fibroblasts. 
Subsequently, vimentin IFs appear to assemble from this re- 
gion toward the periphery of the cell until a normal appear- 
ing vimentin IF network is formed (70).  The similar results 
reported in this study for the vimentin network of PtK2 cells 
emphasize that separate mechanisms are utilized in the as- 
sembly and maintenance of the endogenous keratin and vi- 
mentin IF systems within a  single cell type. On the other 
hand, incorporation of  chicken vimentin in stably transfected 
mouse fibroblasts appears  first as a  discontinuous pattern 
throughout the entire vimentin IF network (46),  suggesting 
multiple sites of cotranslational or posttranslational assem- 
bly along the endogenous system. After 24 h, newly synthe- 
sized vimentin colocalizes with the endogenous vimentin-IF 
network (46).  Therefore, it appears that microinjected and 
newly synthesized IF proteins may follow different pathways 
for assembly into endogenous polymerized IF networks. 
The results with the microinjected type I keratins are in- 
triguing as numerous studies have demonstrated that type I 
and type II proteins are required for the formation of the het- 
erodimers needed for IF assembly (14,  18, 30, 42, 58, 62). 
Our in vitro results support these findings; the purified type 
I bovine tongue keratin cannot assemble into IF in vitro un- 
less it is mixed with its type II counterpart. The lack of any 
obvious keratin IF formation after microinjection of type I 
keratin into BHK-21 fibroblasts in this study provides further 
evidence that both type I and type II are required for IF for- 
mation in vivo. 
Considering the rapid rate of  incorporation of the microin- 
jected type I keratin and in general the low level of biosyn- 
thesis of keratin (15), it is unlikely that the excess of type I 
protein complexes with a sufficient amount of newly synthe- 
sized type II protein to account for the formation of the het- 
erodimers required for the IF/tonofilament assembly seen 
over the time course of our experiments. This is further sup- 
ported by the finding that even when 90-95 % of protein syn- 
The Journal of Cell Biology, Volume  113, 1991  852 Figure 9. BHK-21 cells (A and B) were microinjected with biotinylated type I keratin. After 4 h the cells were fixed and stained using 
goat antibiotin (A). A phase-contrast micrograph of the same cell as in A is shown in B. Bar, 10 #m. 
thesis is inhibited by cycloheximide  treatment, microinjected 
type I keratin still becomes incorporated into endogenous IF 
networks  over  short  time  periods.  Therefore,  it  appears 
likely that a dynamic equilibrium exists in vivo which pro- 
vides a small, most likely transient pool of monomeric kera- 
tin.  This would allow for the formation of hybrid hetero- 
dimers containing biotinylated type I/unbiotinylated type II 
protein chains. Such heterodimers could then participate in 
IF formation and maintenance. This hypothesis could also 
account for the lack of colocalization between antibiotin and 
mAb anti-K seen at the thin edges of PME cells 30-45 min 
after injection (Fig. 4, C and D). We speculate that the tono- 
filament-like structures seen in this region with antibiotin 
may result from the pairing of microinjected biotinylated 
type I keratin with endogenous type II keratins not recog- 
nized by mAb anti-K (see Fig. 3). At this juncture it should 
be emphasized that we cannot formally rule out the possibil- 
ity that biotinylated homodimers might also be assembling 
into IF in these peripheral regions devoid of detectable en- 
dogenous tonofilaments. In support of this latter possibility, 
Steinert (58) has shown that some homodimers may partici- 
pate in IF formation when assembled from urea solubilized 
preparations. 
As  indicated  above,  biotinylated keratin  is  also  found 
aligned with tonofilaments in regions of PME cell-cell con- 
tact containing desmosomes (see Fig. 5, A and B). Thus, it 
appears that microinjected keratin is also incorporated into 
tonofilaments at the cell surface (32, 33).  However, there is 
no evidence from our work that desmosomes preferentially 
nucleate the assembly of keratin IF, a  function which has 
been suggested for desmosomes of a rat mammary epithelial 
cell line (9).  In fact, incorporation of biotinylated keratin 
into tonofilaments associated with desmosomes appears to 
occur at the same rate as seen throughout the entire keratin 
network. 
In summary,  biotinylated  type  I keratin incorporates rapidly 
into tonofilaments in epithelial cells as assayed by immuno- 
fluorescence  microscopy. The rate of  incorporation into tono- 
fibrils suggests that subunit exchange occurs in vivo at the 
posttranslational level of regulation. The data presented in 
this study are consistent with the view that the keratin IFs 
comprising tonofilaments are dynamic structures in vivo. 
Furthermore, the use of biotinylated and/or fluorochrome- 
labeled keratin in future studies should yield important in- 
formation regarding IF and their interactions with other cy- 
toskeletal elements and organelles; and ultimately should 
shed light on the mechanisms underlying the changes in IF 
composition which take place during cellular differentiation. 
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